Medestea Research & Production S.p.A. - Product Pipeline Review - 2014

Published: Oct, 2014 | Pages: 34 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Medestea Research & Production S.p.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Medestea Research & Production S.p.A. - Product Pipeline Review - 2014', provides an overview of the Medestea Research & Production S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Medestea Research & Production S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Medestea Research & Production S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Medestea Research & Production S.p.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Medestea Research & Production S.p.A.'s pipeline products

Reasons to buy

- Evaluate Medestea Research & Production S.p.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Medestea Research & Production S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Medestea Research & Production S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Medestea Research & Production S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Medestea Research & Production S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Medestea Research & Production S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Medestea Research & Production S.p.A. Snapshot 5
Medestea Research & Production S.p.A. Overview 5
Key Information 5
Key Facts 5
Medestea Research & Production S.p.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Medestea Research & Production S.p.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Medestea Research & Production S.p.A. - Pipeline Products Glance 11
Medestea Research & Production S.p.A. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Medestea Research & Production S.p.A. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Medestea Research & Production S.p.A. - Drug Profiles 15
Lysine Acetylsalicylate 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
AT-20 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Adipose Tissue Derived Stem Cells 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Deina 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
doxorubicin pegylated liposome 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
IAC VITA 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
MED-1101 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Tribarcina 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
U-94 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Medestea Research & Production S.p.A. - Pipeline Analysis 27
Medestea Research & Production S.p.A. - Pipeline Products by Target 27
Medestea Research & Production S.p.A. - Pipeline Products by Route of Administration 28
Medestea Research & Production S.p.A. - Pipeline Products by Molecule Type 29
Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action 30
Medestea Research & Production S.p.A. - Dormant Projects 31
Medestea Research & Production S.p.A. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34

List of Tables
Medestea Research & Production S.p.A., Key Information 5
Medestea Research & Production S.p.A., Key Facts 5
Medestea Research & Production S.p.A. - Pipeline by Indication, 2014 7
Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2014 9
Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2014 10
Medestea Research & Production S.p.A. - Phase II, 2014 11
Medestea Research & Production S.p.A. - Phase I, 2014 12
Medestea Research & Production S.p.A. - Preclinical, 2014 13
Medestea Research & Production S.p.A. - Discovery, 2014 14
Medestea Research & Production S.p.A. - Pipeline by Target, 2014 27
Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2014 28
Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2014 29
Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2014 30
Medestea Research & Production S.p.A. - Dormant Developmental Projects,2014 31
Medestea Research & Production S.p.A., Other Locations 32